ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Salt Lake City, UT, USA:

A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy (PEVENAZA)

to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Pevonedistat
Drug: Venetoclax

Phase 2

Takeda
Takeda

Salt Lake City, Utah, United States and 56 other locations

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

LLS PedAL Initiative, LLC

Salt Lake City, Utah, United States and 78 other locations

Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Gilteritinib
Drug: Daunorubicin

Phase 2

PrECOG

Salt Lake City, Utah, United States and 43 other locations

This is a Phase 1/2a, multicenter, open-label, first-in-human (FIH) study of VOR33 in participants with AML or MDS who are undergoing human ...

Enrolling
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Drug: Mylotarg
Biological: VOR33

Phase 1, Phase 2

Vor Biopharma

Salt Lake City, Utah, United States and 14 other locations

). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Tagraxofusp

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Salt Lake City, Utah, United States and 35 other locations

T cell therapy (VCAR33) in patients with relapsed or refractory Acute Myeloid Leukemia (AML) after human leukocyt...

Enrolling
Leukemia, Myeloid, Acute
Biological: VCAR33

Phase 1, Phase 2

Vor Biopharma

Salt Lake City, Utah, United States and 13 other locations

Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Salt Lake City, Utah, United States and 171 other locations

Locations recently updated

with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...

Enrolling
Acute Myeloid Leukemias
Drug: SNDX-5613
Drug: Chemotherapy Regimen

Phase 1

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Salt Lake City, Utah, United States and 22 other locations

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Salt Lake City, Utah, United States and 221 other locations

Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia...

Enrolling
Mast Cell Leukemia (MCL)
SM With an Associated Hematologic Neoplasm (SM-AHN)
Drug: bezuclastinib

Phase 2

Cogent Biosciences

Salt Lake City, Utah, United States and 41 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems